U.S. Oil and Gas Stock News

NasdaqGS:GPRE
NasdaqGS:GPREOil and Gas

Is It Too Late To Consider Green Plains (GPRE) After A 345% One Year Surge?

Investors may be wondering if Green Plains at US$15.92 is still attractively priced after a strong run, or if they might be late to the story. The stock has returned 7.4% over the last week and 54.9% year to date, with a 344.7% return over the past year contrasting with weaker 3- and 5-year figures of negative 53.4% and negative 46.6%. Recent coverage has focused on Green Plains as an actively traded biofuels name, with attention on how the share price has shifted alongside changing...
NYSE:TPR
NYSE:TPRLuxury

Is It Too Late To Consider Tapestry (TPR) After A 115% One-Year Share Price Surge?

If you are wondering whether Tapestry's share price still offers value after a strong run, it helps to step back and look at what the current price might be implying. The stock most recently closed at US$145.89, with returns of 13.0% year to date and 114.9% over the last year. Over the last 7 days the share price declined 6.4%, and over the last 30 days it was roughly flat with a 0.2% slip. Recent headlines have focused on Tapestry's position in the luxury space and how investor sentiment...
NYSE:EPAM
NYSE:EPAMIT

EPAM Awards Spotlight AI And Cloud Ambitions After Share Price Slide

EPAM Systems (NYSE:EPAM) has been named a 2026 Google Cloud Partner of the Year in two categories. The awards recognize EPAM's work in AI driven solutions, sustainability, and complex cloud migrations. This recognition highlights EPAM's role in delivering measurable business outcomes for enterprise clients on Google Cloud. For investors following EPAM Systems at a current share price of $118.98, this new recognition arrives after an extended period of weak share performance, including a...
NasdaqGS:LIFE
NasdaqGS:LIFEInsurance

Is It Too Late To Consider Ethos Technologies (LIFE) After The Recent 66% Rally?

If you are wondering whether Ethos Technologies at around US$16.77 still offers value or is already pricing in a lot of optimism, you are not alone. The stock has moved 3.5% over the last 7 days and 66.0% over the last 30 days, while the year to date return is around a 0.5% decline. This raises clear questions about what is now baked into the price. Recent coverage has focused on Ethos Technologies as part of a broader look at insurance names, highlighting how sentiment can shift quickly...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

Is It Too Late To Consider Pebblebrook Hotel Trust (PEB) After A 52.9% Rally?

Wondering whether Pebblebrook Hotel Trust at around US$13.96 still offers value, or if the easy upside is gone? A useful starting point is understanding how its price stacks up against its fundamentals. The stock has delivered a 52.9% return over the last year, with gains of 20.9% year to date and 9.4% over the last month. However, the 3 year and 5 year returns of a 1.0% decline and a 40.7% decline show a very different longer term picture. Recent coverage has focused on how hotel and resort...
NYSE:WCN
NYSE:WCNCommercial Services

Waste Connections Uses AI To Shape Margins Retention And M&A Outlook

Waste Connections (NYSE:WCN) is rolling out AI-driven pricing tools that are materially affecting operating performance. The company reports visible margin expansion linked to these AI tools, along with stronger pricing retention and better employee and customer retention. Special waste volume growth and continued M&A activity are additional areas of focus alongside the AI initiatives. Waste Connections, a major solid waste services provider, is using artificial intelligence to refine how...
NYSE:NSC
NYSE:NSCTransportation

Norfolk Southern (NSC) Net Margin Expansion To 23.6% Tests Bullish Efficiency Narrative

Norfolk Southern (NSC) has just posted its latest numbers, with Q4 2025 revenue of US$2,974 million and basic EPS of US$2.86, setting the stage for its Q1 2026 update against a trailing 12 month backdrop of US$12.8 billion in revenue and basic EPS of US$12.76. Over recent quarters the company has seen revenue move from US$2,993 million in Q1 2025 to US$3,110 million in Q2 2025 and US$3,103 million in Q3 2025, while quarterly basic EPS shifted from US$3.31 to US$3.41 and then to US$3.17 across...
NYSE:LAZ
NYSE:LAZCapital Markets

Is Lazard (LAZ) Attractively Priced After Recent 27.6% One Year Share Price Gain

If you are wondering whether Lazard at around US$47.30 represents fair value or a potential bargain, this article breaks down what that price really represents. The stock has seen mixed recent returns, with a 3.5% decline over the last 7 days, a 15.6% gain over the last 30 days, a 4.9% decline year to date and a 27.6% return over the past year, alongside 74.9% and 33.9% returns over 3 and 5 years respectively. These moves sit against an ongoing flow of company and industry updates that...
NYSE:POR
NYSE:PORElectric Utilities

Did PGE’s 5% Dividend Hike Just Reframe Portland General Electric’s (POR) Capital Allocation Story?

On April 24, 2026, Portland General Electric’s board approved a 5% increase in its quarterly dividend to US$0.55125 per share, payable on or before July 15, 2026, to shareholders of record as of June 25, 2026, aligning with its long-term 60–70% payout ratio target. This dividend increase highlights how PGE is balancing shareholder returns with capital needs for grid modernization and clean energy investment, amid ongoing regulatory and demand shifts. We’ll now examine how PGE’s higher...
NYSE:PMT
NYSE:PMTMortgage REITs

PennyMac’s Team USA Athlete Mortgage Push Might Change The Case For Investing In PMT

PennyMac Financial Services and PennyMac Mortgage Investment Trust recently launched the “Welcome Home: Athlete Mortgage Program,” extending specialized mortgage guidance, exclusive benefits, and educational resources to the wider Team USA athlete community in partnership with the U.S. Olympic & Paralympic Committee. The initiative highlights Pennymac’s effort to cultivate a differentiated client base by tailoring lending support to the unique financial profiles of elite athletes. Next,...
NasdaqCM:ATOM
NasdaqCM:ATOMSemiconductor

Could Atomera’s Expanded Synopsys GaN Partnership Quietly Reshape Its Licensing Power Story (ATOM)?

Atomera Incorporated recently announced it has expanded its long-running collaboration with Synopsys to develop gallium nitride (GaN) device modeling workflows for radio frequency and power semiconductor applications using Synopsys’ Sentaurus TCAD and Atomera’s MSTcad toolset. This move extends Atomera’s MST modeling capabilities into GaN, potentially deepening its role in high-value RF and power markets by integrating more tightly into Synopsys’ widely used design ecosystem. We’ll now...
NasdaqCM:EVLV
NasdaqCM:EVLVElectronic

Major Arena Deals Might Change The Case For Investing In Evolv Technologies Holdings (EVLV)

Evolv Technologies Holdings, Inc. recently announced multi-year subscription agreements and marketing partnerships with the University of Washington’s athletic department and Crypto.com Arena, expanding deployments of its Evolv Express Gen2 and eXpedite AI-based screening systems across major college and professional sports venues. These high-traffic stadium and arena wins highlight growing adoption of Evolv’s subscription-based security platforms in sports and entertainment, reinforcing its...
NYSE:LUCK
NYSE:LUCKHospitality

A Look At Lucky Strike Entertainment (LUCK) Valuation After Rebrand And Share Price Pullback

Recent share performance and business snapshot Lucky Strike Entertainment (LUCK) has drawn attention after a recent pullback, with the share price closing at US$7.24 as investors reassess the business following its rebrand from Bowlero Corp. The company runs a portfolio of bowling centers and entertainment venues across North America, including AMF, Bowl America, Lucky Strike, Bowlero, Octane Raceway, several water parks, and Boomers Parks. It has reported revenue of US$1,240.203 million and...
NasdaqGS:SKYW
NasdaqGS:SKYWAirlines

SkyWest (SKYW) Margins Hold Above 10% In Q1 2026 Challenging Cautious Narratives

SkyWest (SKYW) has kicked off Q1 2026 with total revenue of US$1.0b, basic EPS of US$2.54 and net income of US$101.7 million, setting the tone for its latest set of results. The company has seen quarterly revenue move from US$948.5 million in Q1 2025 to US$1.0b in Q1 2026, while basic EPS has shifted from US$2.48 to US$2.54 over the same period, against a backdrop of trailing 12 month EPS of US$10.69 and net income of US$429.5 million. With a trailing net margin of 10.4% versus 9.9% the prior...
NYSE:AESI
NYSE:AESIEnergy Services

Is Atlas Energy Solutions (AESI) Still Attractive After Its Recent Share Price Surge?

Wondering if Atlas Energy Solutions at around US$16.31 offers good value for your money? This article focuses on what the current share price might mean for long-term investors. The stock has shown sharp recent moves, with returns of 22.7% over 7 days, 20.3% over 30 days, 67.8% year to date and 19.1% over the past year. These figures can change how you think about both potential upside and risk. Recent coverage has centered on Atlas Energy Solutions as investors reassess US energy services...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Newell Brands Lawsuit Puts CrockPot Safety And Valuation Gap In Focus

A new product liability lawsuit alleges a design flaw in Newell Brands' CrockPot Express Crock Multicooker led to severe burn injuries when the lid opened while still under pressure. The case targets Newell Brands, listed as NasdaqGS:NWL, and focuses on product safety controls and consumer protection around its popular small appliance line. Newell Brands, through its CrockPot range, is a familiar name in many kitchens, so any allegation around product safety can quickly draw attention from...
NasdaqGM:ATAI
NasdaqGM:ATAIPharmaceuticals

AtaiBeckley’s EMP-01 Data Strengthen Case For Psychedelic Anxiety Pipeline

AtaiBeckley reported detailed Phase 2a data for its oral R-MDMA candidate EMP-01 in adults with Social Anxiety Disorder. The trial showed strong and consistent efficacy, with meaningful improvements in clinician- and patient-reported symptoms and real world behavioral outcomes. EMP-01 was found to be safe and well tolerated, with high participant retention and no serious adverse events, and the results were achieved without adjunctive psychotherapy. For AtaiBeckley, listed on NasdaqGM:ATAI,...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Amneal Kashiv Deal Shifts Biosimilar Growth And Valuation Story

Amneal Pharmaceuticals (NasdaqGS:AMRX) has agreed to acquire Kashiv BioSciences, creating a fully integrated global biosimilars platform. The transaction is expected to accelerate Amneal's biosimilar pipeline and support multiple planned biosimilar launches over the coming years. The combination brings together Kashiv's development capabilities with Amneal's commercial infrastructure and established generics franchise. Amneal Pharmaceuticals, trading at around $12.52, has seen a very large...